TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 EUR)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
575
|
559 | |
| Financial expenses |
0
|
32 | |
| Earnings before taxes |
399
|
346 | |
| EBITDA |
364
|
181 | |
| Total assets |
1,935
|
1,668 | |
| Current assets |
754
|
727 | |
| Current liabilities |
249
|
176 | |
| Equity capital |
1,657
|
1,407 | |
| - share capital |
4
|
5 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
85.6%
|
84.4% | |
| Turnover per employee |
288
|
280 | |
| Profit as a percentage of turnover |
69.4%
|
61.9% | |
| Return on assets (ROA) |
20.6%
|
22.7% | |
| Current ratio |
302.8%
|
413.1% | |
| Return on equity (ROE) |
24.1%
|
24.6% | |
| Change turnover |
44
|
115 | |
| Change turnover % |
-12%
|
8%
|
26% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.